Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Overdose deaths are down, but the fentanyl crisis is far from over. On National Fentanyl Prevention and Awareness Day, experts are calling for a shift from treating overdoses to preventing them — using tools like fentanyl test strips, real-time detection devices, and non-judgmental conversations between clinicians and patients. Nearly 49,000 Americans still died from synthetic opioids in 2024.
The U.S. has made real progress on opioid overdose deaths — but experts say now is not the time to ease up. On National Fentanyl Prevention and Awareness Day (August 21), specialists are urging a strategic pivot: from reversing overdoses to preventing them in the first place. The core message? Fentanyl doesn't just affect people with opioid use disorder — it's contaminating stimulants, counterfeit pills, and other drugs, putting a much broader population at risk.
Clinicians are being called to ask about substance use without judgment, proactively offer naloxone, and discuss fentanyl detection tools as standard harm reduction practice. Emerging devices like DEFENT ONE can test substances in real time and even map geographic clusters of dangerous drug supply — a step upstream from naloxone, which only acts after an overdose has already begun.
By the Numbers:
Why it matters: The recent decline in overdose deaths is encouraging, but experts warn the gains are fragile. Expanded naloxone access and behavioral shifts — not a significant drop in fentanyl supply — are driving the improvement. Sustained investment in upstream prevention, detection tools, and harm reduction infrastructure is essential to making this progress last.
